This course presents key market opportunities by equipping professionals in the pharmaceutical industry with essential skills for seamless technology transfer and scale-up of solid dosage forms.

Type-3 New Drug Applications, focusing on new dosage forms, dominate the 505(b)(2) pathway approvals, with injectable formulations being the largest category. Stability and manufacturing consistency ...

Most drugs in the U.S. are taken orally because these oral dosage forms have a significant systemic effect on the body after being absorbed from different surfaces along the gastrointestinal tract ...